4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000035
Chief Scientific Officer acquired 4,455,827 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-04-26 | Other acquisition | +4,455,827 | $0.04 | $164,420 | 9,399,712 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NIGALAYE ASHOK G Chief Scientific Officer | 2013-04-26 | Other acquisition · Warrants | +4,424,333 | 26,727,001 | I: show line 2 in the form |
Loading xslF345X03/primary_doc.xml…